Last month, new legislation was overwhelmingly passed to expand the scope of the Committee on Foreign Investment in the United States (CFIUS). Two versions are currently being hashed out, but whatever the outcome, it will impact private equity through stricter oversight of cross-border investment, probably including at least some new restrictions on the transfer of minority interests. At present, the committee only considers buyouts.
A&M’s James Dubow and Eric Wang weigh in on how to handle an expected increase in supply chain-related efficiency problems.
This article was previously published in the July 5, 2018 issue of Asian Venture Capital Journal.
Redcliffe Labs Divests Crysta IVF to Moon Care Private Limited to Strengthen Focus on Diagnostics
April 10, 2026
Redcliffe Labs, India's fastest-growing diagnostic healthcare network built on a preventive-first approach, today announced the strategic divestment of its fertility services business, Crysta IVF, to Moon Care Private Limited, the healthcare arm of the MMG Group. Alvarez & Marsal acted as the exclusive advisor to the transaction.
Annie Peabody on Quarterly Reporting and Investor Pressure in Chief Executive Feature
April 9, 2026
In a recent Chief Executive feature, Annie Peabody examines how investor scrutiny—not proposed quarterly reporting changes—is driving short term pressures and reshaping how companies communicate corporate value narratives, performance, and strategy.
THE RETURN OF SECTION 301: WHAT DOES IT MEAN FOR APAC?
April 9, 2026
Section 301 is reshaping APAC trade. Explore risks from excess capacity probes and forced labor enforcement, plus tariff scenarios and mitigation steps.
Software and Tech Private Equity Outlook: Leverage AI Effectively or Get Left Behind in 2026
April 9, 2026
Selective buying will define software & tech private equity. Capital will favor AI-ready leaders who can differentiate, as buyers focus on the best positioned.
